Kernicterus in the 21st century: frequently asked questions

V K Bhutani1, L Johnson

  • 1Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Children's Hospital, Stanford, CA, USA. bhutani@stanford.edu

Insights

Severe neonatal hyperbilirubinemia poses a risk for kernicterus, a preventable brain injury. Current estimates suggest a significant risk of chronic kernicterus in infants with total serum bilirubin levels exceeding 30 mg/dL.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Public Health

Background:

  • Acute kernicterus is a preventable neonatal brain injury resulting from delayed management of hyperbilirubinemia.
  • Practitioners frequently question the risks and timing of bilirubin-related neurotoxicity in infants.
  • There is ongoing concern regarding the re-emergence and incidence of kernicterus in the United States.

Purpose of the Study:

  • To address critical questions regarding bilirubin neurotoxicity in infants.
  • To evaluate the risk and incidence of kernicterus and severe neonatal hyperbilirubinemia.
  • To determine safe bilirubin thresholds and assess sequelae of hyperbilirubinemia.

Main Methods:

  • Review and analysis of available data and evidence on neonatal hyperbilirubinemia.
  • Estimation of the current risk of kernicterus in infants with elevated total serum bilirubin (TSB).
  • Assessment of the impact of the 1994 American Academy of Pediatrics Guidelines.

Main Results:

  • The study estimates the current risk of chronic kernicterus to be approximately 1 in 7 for infants with TSB >30 mg/dL (513 micromol/L).
  • Addresses questions on whether bilirubin damages healthy infant brains and the specific TSB thresholds for neurotoxicity.
  • Discusses the incidence of kernicterus and severe neonatal hyperbilirubinemia in the current era.

Conclusions:

  • Delayed management of neonatal hyperbilirubinemia can lead to preventable brain injury.
  • A TSB level >30 mg/dL poses a substantial risk for chronic kernicterus.
  • Further research and clinical vigilance are necessary to prevent kernicterus and its sequelae.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...